CCRN

Cross Country Healthcare Inc

Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, local nurses, and allied staffing; staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, RPO, and consulting services. It also provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. This segment serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.

Cross Country Healthcare Inc (CCRN) is rated C (2.2/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (C+); its weakest is Profitability (C-). The rating has held at C for 83 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.2 / 5.0
C
Value
C+
Factor Score 2.6 / 5.0
Growth
C
Factor Score 2.3 / 5.0
Profitability
C-
Factor Score 1.9 / 5.0
Momentum
C
Factor Score 2.4 / 5.0
Revisions
C-
Factor Score 1.9 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 0.0
EV / EBITDA 66.4
Rev Growth YoY -17.8%
Gross Margin 20.2%
Price Return 3M 28.6%
Price Return 12M -2.6%
Catalyst Signal 0.00
Market Cap N/A
TTM Revenue N/A
Price / Sales 0.4
ROE -27.0%

Historical Factor Score Progression

Held C for 83 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-08-05 C+ (2.6) C (2.3) C- (1.9) C (2.4) C- (1.9) C (2.2)
2026-08-04 C+ (2.6) C (2.3) C- (1.9) C (2.4) C- (1.9) C (2.2)
2026-08-03 C+ (2.6) C (2.4) C (2.4) C (2.4) C- (2.0) C (2.4)
2026-08-02 C+ (2.7) C (2.4) C (2.4) C (2.4) C- (1.9) C (2.4)
2026-07-29 C (2.5) D+ (1.5) C- (2.1) B (3.4) D+ (1.5) C (2.2)
Page 1 of 2